Global Hemodynamic Monitoring Market Insights Forecasts to 2033

• The Global Hemodynamic Monitoring Market Size was Valued at USD 1.55 Billion in 2023
• The Market Size is Growing at a CAGR of 5.90% from 2023 to 2033
• The Worldwide Hemodynamic Monitoring Market Size is Expected to Reach USD 2.75 Billion by 2033
• Asia-Pacific is expected to Grow the fastest during the forecast period.

The Global Hemodynamic Monitoring Market Size is Anticipated to Exceed USD 2.75 Billion by 2033, Growing at a CAGR of 5.90% from 2023 to 2033.

Market Overview

Hemodynamic monitoring devices are used for screening blood flow that aids in identifying the heart function (cardiovascular status) which subsequently guides treatment decisions. It is also used to monitor temporary declines in blood flow to the brain, sudden drops in blood pressure or heart rate, and changes in blood volume or distribution by using devices such as EKG monitoring, blood pressure monitoring, hemodynamic echo, and nuclear medicine imaging. The type of hemodynamic monitoring device used depends upon the condition of the patient. ECG monitoring, regular non-invasive blood pressure measurement, and peripheral pulse oximetry (peripheral oxygen saturation or SpO2) are commonly used devices for patients with stable hemodynamic conditions. In the case of an unstable person, the patient should receive an arterial line for continuous invasive blood pressure measurement and regular analysis of arterial blood gasses. It is used to diagnose types of shock like hypovolemic, cardiogenic, obstructive, or distributive according to the hemodynamic profile. Hemodynamic monitoring aims to manage medical conditions that are likely to cause hypovolemia, cardiac dysfunction, or alterations of vasomotor function, leading to organ dysfunction, deterioration into multi-organ failure, and eventually death. According to the American Lung Association, the prevalence of COPD in the U.S. was estimated at 6.2% of the total population. The growing demand for patient monitoring devices in non-hospital settings and emerging economies (such as China, India, Brazil, and Mexico) is expected to offer lucrative growth opportunities for hemodynamic monitoring.

Report Coverage

This research report categorizes the market for the global hemodynamic monitoring market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global hemodynamic monitoring market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global hemodynamic monitoring market.

Driving Factors

The rising cases of cardiovascular, COPD, and respiratory diseases increasing the market demand for hemodynamic monitoring to diagnose hemodynamic conditions. According to the American Heart Association, the age-adjusted prevalence of cardiovascular disease (CVD) was 7,354.1 per 100,000 population across the globe in the year 2020.  The advancement in surgical procedure techniques and the development of novel non-invasive & minimally invasive systems are expected to increase the market demand for hemodynamic monitoring. The launch of new and innovative hemodynamic monitoring devices helps to improve the management of cardiovascular patients with accurate measurements and the ability to detect hemodynamic alterations. The transition from static to dynamic variable monitoring and the development of minimally invasive monitoring techniques contributed to the market growth of hemodynamic monitoring.       

Restraining Factors

The risk factors related to hemodynamic monitoring systems such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis impede market growth. The lack of awareness among patients regarding disease diagnosis and skilled professionals is negatively affecting the market growth of hemodynamic monitoring devices. Further, the increased price of hemodynamic monitoring devices by market players hampering the market.

Market Segmentation

The global hemodynamic monitoring market share is classified into system type, product, and end-use.

• The non-invasive segment is expected to hold the largest share of the global hemodynamic monitoring market during the forecast period.   

Based on the system type, the global hemodynamic monitoring market is categorized into invasive, minimally invasive, and non-invasive. Among these, the non-invasive segment is expected to hold the largest share of the global hemodynamic monitoring market during the forecast period. Blood pressure monitoring is the prime factor responsible for increasing the market demand. The non-invasive hemodynamic monitoring devices are extensively used in different clinical settings, such as outpatient clinics, general wards, and home care, to monitor patients’ cardiovascular parameters. Getinge introduced NICCI, a cutting-edge non-invasive monitoring system to reduce the problems brought on by low blood pressure, in October 2020.

• The monitors segment is expected to grow at the fastest CAGR during the forecast period.   

Based on the product, the global hemodynamic monitoring market is categorized into disposables and monitors. Among these, the monitors segment is expected to grow at the fastest CAGR during the forecast period. The rising investment by major manufacturers for the development of patient-centric care and bringing technologically advanced products into the market is driving the hemodynamic monitors demand.

• The hospital segment is expected to hold a significant share of the global hemodynamic monitoring market during the forecast period.

Based on the end-use, the global hemodynamic monitoring market is categorized into hospitals, clinics & ambulatory care centers, and home care settings. Among these, the hospital segment is expected to hold a significant share of the global hemodynamic monitoring market during the forecast period. The management of high-acuity patients, such as heart failure patients, sepsis, and shock in hospitals creates market demand for hemodynamic monitoring. According to NCBI, an estimated 1.7 million patients suffer from sepsis annually in the U.S. In addition, hospitals perform invasive surgeries, which necessitates the demand for accurate hemodynamic monitoring devices.

Regional Segment Analysis of the Global Hemodynamic Monitoring Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global hemodynamic monitoring market over the predicted timeframe.

North America is projected to hold the largest share of the global hemodynamic monitoring market over the forecast period. The advancement in healthcare infrastructure and the faster rate of technological advancement in the region are likely to enhance the market. The high prevalence rate of cardiovascular diseases among the growing geriatric population and high healthcare expenditure increase the market demand of hemodynamic monitoring. According to Rural Health Information Hub, the geriatric population in the U.S. is expected to increase by 18 million between 2020 – 2030.

Asia-Pacific is expected to grow at the fastest CAGR growth of the global hemodynamic monitoring market during the forecast period. The increasing hemodynamic monitoring device product approvals in China and Japan are expected to influence the market. The National Medical Products Association (NMPA) approved Medtronic's Evolut PRO TAVR System in January 2022. Some of the factors driving market growth in the APAC region include Japan's growing healthcare industry, extensive government reimbursement coverage for critical cardiac procedures, and improving healthcare infrastructure in India and China.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global hemodynamic monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Edwards Lifesciences Corporation
• PULsion Medical Systems SE
• LiDCO Group Plc.
• Baxter
• Deltex Medical Group
• ICU Medical
• GE Healthcare
• OsypkaCardiotek GmbH
• Koninklijke Philips N.V.
• Masimo
• Getinge AB
• Tensys Medical Inc.
• Schwarzer Cardiotek GmbH
• Deltex Medical
• CNSYSTEMS MEDIZINTECHNIK GMBH
• ICU Medical Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent developments

• In May 2023, Inspira Technologies OXY B.H.N. Ltd. announced the development of VORTX, a respiration technology that is expected to improve hemodynamic performance and reduce oxygenator failures.

• In March 2021, the FDA granted De Novo classification to Fifth Eye’s continuous hemodynamic status monitoring tool. The Analytic for Hemodynamic Instability tool can identify hemodynamic instability with 96% sensitivity and detect stable patients with 85% specificity.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global hemodynamic monitoring market based on the below-mentioned segments: 

Global Hemodynamic Monitoring Market, By System Type

• Invasive
• Minimally Invasive
• Non-Invasive

Global Hemodynamic Monitoring Market, By Product

• Disposables
• Monitors

Global Hemodynamic Monitoring Market, By End-use

• Hospitals
• Clinics & Ambulatory Care Center
• Home Care Setting

Global Hemodynamic Monitoring Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa